Publication date: Available online 6 October 2026 Source: Obesity Research & Clinical Practice Author(s): Payam Peymani, Laila Aboulatta, Mohd Wasif Khan, Roxana Dragan, Sherif Eltonsy
Temporal trends in GLP-1 receptor agonist and SGLT2 inhibitor dispensing during pregnancy in Manitoba, Canada, 2015–2023. // Obesity Research & Clinical Practice. – URL: https://www.sciencedirect.com/science/article/pii/S1871403X2600092X?dgcid=rss_sd_all
Temporal trends in GLP-1 receptor agonist and SGLT2 inhibitor dispensing during pregnancy in Manitoba, Canada, 2015–2023. Obesity Research & Clinical Practice. https://www.sciencedirect.com/science/article/pii/S1871403X2600092X?dgcid=rss_sd_all
“Temporal trends in GLP-1 receptor agonist and SGLT2 inhibitor dispensing during pregnancy in Manitoba, Canada, 2015–2023.” Obesity Research & Clinical Practice.
@article{article60589,
title = {Temporal trends in GLP-1 receptor agonist and SGLT2 inhibitor dispensing during pregnancy in Manitoba, Canada, 2015–2023},
journal = {Obesity Research \& Clinical Practice},
url = {https://www.sciencedirect.com/science/article/pii/S1871403X2600092X?dgcid=rss_sd_all}
}